Malignant hyperthermia susceptibility is often caused by a specific gene mutation. Only 1 parent has to have the defective gene for the child to inherit the susceptibility.
A malignant hyperthermia event is caused by abnormal levels of calcium in the muscle. The change in calcium causes an increase in metabolism. Heat is a side-effect of metabolism.
|Copyright © Nucleus Medical Media, Inc.|
The abnormal levels of calcium often are triggered by medications used for anesthesia such as:
- Certain inhaled anesthesia gases
- Certain muscle relaxants
Malignant hyperthermia is an emergency. It is often suspected based on symptoms and recent anesthesia administration.
Malignant hyperthermia susceptibility may be suspected based on your medical and family history. If you have a positive family history, then your doctor may test you for the susceptibility with:
- Genetic testing
- Muscle biopsy —a sample of muscle tissue is taken and examined under a microscope
If the condition was triggered by a certain anesthetic, it will be stopped and/or changed.
Emergency care will be given and may include:
- Ending surgery
- Cooled IV fluids and blankets to reduce your temperature
- Oxygen therapy to reduce damage caused by high temperature
- Medications to slow muscle metabolism, control breathing and heart rate.
Kidney and heart tests may also be done to look for any potential complications from the hyperthermia event.
Make sure all of your doctors are aware of your susceptibility to malignant hyperthermia or any family history of malignant hyperthermia.
- Discuss these facts before any surgery or medical procedure. This will allow your doctor to select medications that are less likely to trigger malignant hyperthermia.
- Wear a medical alert bracelet to let emergency responders know about your condition. The bracelet will speak for you if you are unable to do so.
If you think there may be malignant hyperthermia susceptibility in your family, talk to your doctor about genetic testing as part of your family planning process.
This content is reviewed regularly and is updated when new and relevant evidence is made available. This information is neither intended nor implied to be a substitute for professional medical advice. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with questions regarding a medical condition.
Edits to original content made by Denver Health.
Copyright © EBSCO Information Services
All rights reserved.
a (Malignant hyperpyrexia; Malignant Hyperthermia Susceptibility)
American Association of Neuromuscular and Electrodiagnostic Medicine http://aanem.org
Malignant Hyperthermia Association of the United States http://www.mhaus.org
CORD—Canadian Organization for Rare Disorders http://www.raredisorders.ca
Health Canada https://www.canada.ca/en/health-canada.html
FAQs: General MH questions. Malignant Hyperthermia Association of the United States website. Available at: http://www.mhaus.org/faqs/category/frequently-asked-questions-about/about-mh/. Accessed September 1, 2017.
Malignant hyperthermia. American Association of Neuromuscular and Electrodiagnostic Medicine website. Available at: http://aanem.org/Patients/Disorders/Malignant-Hyperthermia. Accessed September 3, 2015.
Malignant hyperthermia. EBSCO DynaMed Plus website. Available at: http://www.dynamed.com/topics/dmp~AN~T115406/Malignant-hyperthermia . Updated March 4, 2016. Accessed September 1, 2017.
Malignant hyperthermia FAQ. Wake Forest Baptist Health website. Available at: http://www.wakehealth.edu/Anesthesiology/Malignant-Hyperthermia/Malignant-Hyperthermia-FAQ.htm#who%20gets. Updated June 28, 2016. Accessed September 1, 2017.
Malignant hyperthermia. Patient UK website. Available at: http://patient.info/doctor/malignant-hyperthermia. Updated October 15, 2014. Accessed September 1, 2017.
Testing for MH. Malignant Hyperthermia Association of the United States website. Available at: http://www.mhaus.org/testing. Accessed September 1, 2017.